JENNIFER HORNBACK: Open Payments
NPI 1952497950 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,773 in 93 payments from 19 companies in 2025. Trend: 2023 $1,336 · 2024 $1,852 · 2025 $1,773
Food & beverage: $1,773
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $339 |
| GlaxoSmithKline, LLC. | 14 | $147 |
| Novo Nordisk Inc | 18 | $144 |
| PFIZER INC. | 9 | $142 |
| BridgeBio Pharma, Inc. | 1 | $138 |
| Amgen Inc. | 5 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $123 |
| Lilly USA, LLC | 5 | $97 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| Exact Sciences Corporation | 4 | $71 |
Products named: FARXIGA, Attruby, Kerendia, TRELEGY ELLIPTA, NURTEC ODT, LEQVIO, Wegovy, Cologuard Collection Kit.
Industry payments across NV — which companies pay providers there.
